lartruvo
eli lilly nederland b.v. - olaratumab - sarcoma - antineoplastic agents - lartruvo is indicated in combination with doxorubicin for the treatment of adult patients with advanced soft tissue sarcoma who are not amenable to curative treatment with surgery or radiotherapy and who have not been previously treated with doxorubicin (see section 5.1).
lartruvo 500mg50ml concentrate for solution for infusion vials
eli lilly and company ltd - olaratumab - solution for infusion - 10mg/1ml
lartruvo 190mg19ml concentrate for solution for infusion vials
eli lilly and company ltd - olaratumab - solution for infusion - 10mg/1ml